Journal Article: Achieving high dialysis dose via continuous renal replacement therapy in the setting of metformin associated lactic acidosis. A case series
Reynolds, Hannah V., Pollock, Hamish H G, Apte, Yogesh V. and Tabah, Alexis (2022). Achieving high dialysis dose via continuous renal replacement therapy in the setting of metformin associated lactic acidosis. A case series. A&A practice, 16 (1) e01561, e01561. doi: 10.1213/XAA.0000000000001561
Journal Article: Safety and efficacy of peripheral versus centrally administered vasopressor infusion: a single-centre retrospective observational study
Stolz, Annaliese, Efendy, Rachel, Apte, Yogesh, Craswell, Alison, Lin, Frances and Ramanan, Mahesh (2021). Safety and efficacy of peripheral versus centrally administered vasopressor infusion: a single-centre retrospective observational study. Australian Critical Care, 35 (5), 506-511. doi: 10.1016/j.aucc.2021.08.005
Journal Article: Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Arabi, Yaseen M., Gordon, Anthony C., Derde, Lennie P. G., Nichol, Alistair D., Murthy, Srinivas, Beidh, Farah Al, Annane, Djillali, Swaidan, Lolowa Al, Beane, Abi, Beasley, Richard, Berry, Lindsay R., Bhimani, Zahra, Bonten, Marc J. M., Bradbury, Charlotte A., Brunkhorst, Frank M., Buxton, Meredith, Buzgau, Adrian, Cheng, Allen, De Jong, Menno, Detry, Michelle A., Duffy, Eamon J., Estcourt, Lise J., Fitzgerald, Mark, Fowler, Rob, Girard, Timothy D., Goligher, Ewan C., Goossens, Herman, Haniffa, Rashan, Higgins, Alisa M. ... on behalf of the REMAP-CAP Investigators (2021). Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial. Intensive Care Medicine, 47 (8), 867-886. doi: 10.1007/s00134-021-06448-5
Reynolds, Hannah V., Pollock, Hamish H G, Apte, Yogesh V. and Tabah, Alexis (2022). Achieving high dialysis dose via continuous renal replacement therapy in the setting of metformin associated lactic acidosis. A case series. A&A practice, 16 (1) e01561, e01561. doi: 10.1213/XAA.0000000000001561
Stolz, Annaliese, Efendy, Rachel, Apte, Yogesh, Craswell, Alison, Lin, Frances and Ramanan, Mahesh (2021). Safety and efficacy of peripheral versus centrally administered vasopressor infusion: a single-centre retrospective observational study. Australian Critical Care, 35 (5), 506-511. doi: 10.1016/j.aucc.2021.08.005
Arabi, Yaseen M., Gordon, Anthony C., Derde, Lennie P. G., Nichol, Alistair D., Murthy, Srinivas, Beidh, Farah Al, Annane, Djillali, Swaidan, Lolowa Al, Beane, Abi, Beasley, Richard, Berry, Lindsay R., Bhimani, Zahra, Bonten, Marc J. M., Bradbury, Charlotte A., Brunkhorst, Frank M., Buxton, Meredith, Buzgau, Adrian, Cheng, Allen, De Jong, Menno, Detry, Michelle A., Duffy, Eamon J., Estcourt, Lise J., Fitzgerald, Mark, Fowler, Rob, Girard, Timothy D., Goligher, Ewan C., Goossens, Herman, Haniffa, Rashan, Higgins, Alisa M. ... on behalf of the REMAP-CAP Investigators (2021). Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial. Intensive Care Medicine, 47 (8), 867-886. doi: 10.1007/s00134-021-06448-5
Interleukin-6 receptor antagonists in critically ill patients with Covid-19
The REMAP-CAP Investigators, Apte, Yogesh and Frakking, Thuy (2021). Interleukin-6 receptor antagonists in critically ill patients with Covid-19. New England Journal of Medicine, 384 (16), 1491-1502. doi: 10.1056/nejmoa2100433
Headache, confusion, and behavioral changes - a HaNDL case report
Stolz, Annaliese, Efendy, Rachel and Apte, Yogesh (2021). Headache, confusion, and behavioral changes - a HaNDL case report. European Journal of Medical Case Reports, 5 (5), 133-137. doi: 10.24911/ejmcr/173-1588758405
Apte, Yogesh, Jacobs, Kylie, Shewdin, Shaun, Murray, Andrew, Tung, Luke, Ramanan, Mahesh and Massey, Debbie (2021). Prone positioning in patients with acute respiratory distress syndrome, translating research and implementing practice change from bench to bedside in the era of coronavirus disease 2019. Australian Critical Care, 34 (2), 176-181. doi: 10.1016/j.aucc.2020.08.002
Clinical management practices of life-threatening asthma: an audit of practices in intensive care
Secombe, Paul, Stewart, Penny, Singh, Sunil, Campbell, Lewis, Stephens, Dianne, Tran, Khoa, White, Hayden, Sheehy, Robert, Gibson, Justine, Cooke, Robyn, Townsend, Shane, Apte, Yogesh, Winearls, James, Ferry, Olivia R., Pradhan, Rahul, Ziegenfuss, Marc, Fong, Kwun M., Yang, Ian A., McGinnity, Paul, Meyer, Jason, Walsham, James, Boots, Rob, Clement, Pierre, Bandeshe, Hiran, Gracie, Christopher, Jarret, Paul, Collins, Stephenie, Coulston, Caitlin, Ng, Melisa ... The Critical Care Asthma Investigators (2019). Clinical management practices of life-threatening asthma: an audit of practices in intensive care. Critical Care and Resuscitation, 21 (1), 53-62.
Clinical management practices of life-threatening asthma: an audit of practices in intensive care
Secombe, Paul, Stewart, Penny, Singh, Sunil, Campbell, Lewis, Stephens, Dianne, Tran, Khoa, White, Hayden, Sheehy, Robert, Gibson, Justine, Cooke, Robyn, Townsend, Shane, Apte, Yogesh, Winearls, James, Ferry, Olivia R., Pradhan, Rahul, Ziegenfuss, Marc, Fong, Kwun M., Yang, Ian A., McGinnity, Paul, Meyer, Jason, Walsham, James, Boots, Rob, Clement, Pierre, Bandeshe, Hiran, Gracie, Christopher, Jarret, Paul, Collins, Stephenie, Coulston, Caitlin, Ng, Melisa ... Trout, Melita (2019). Clinical management practices of life-threatening asthma: an audit of practices in intensive care. Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine, 21 (1), 53-62.
An unusual manifestation of cardiac sarcoidosis
Ramanathan, K., Platts, D., Apte, Y. V. and Muthalidas, D. (2014). An unusual manifestation of cardiac sarcoidosis. Sarcoidosis Vasculitis and Diffuse Lung Diseases, 31 (1), 71-75.
Apte, Yogesh, Bellomo, Rinaldo, Warrillow, Stephen, Goldsmith, Donna, Gillies, Michael and McGain, Forbes (2008). Pilot randomised double-blind controlled trial of high-dose spironolactone in critically ill patients receiving a frusemide infusion. Critical Care and Resuscitation, 10 (4), 306-311.